M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
TRxADE HEALTH, Inc to acquire Superlatus, Inc.
Announced Jun 23, 2023 · Closed Jul 31, 2023 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock$58.61 per share
Transaction
- Acquirer
- TRxADE HEALTH, Inc (MEDS)
- Target
- Superlatus, Inc.
- Buyer type
- Strategic
- Offer price per share
- $58.61
- Enterprise value
- —
- Status
- Closed Jul 31, 2023
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations